Cargando…
Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway
miR-27a regulates cell differentiation in a variety of diseases. However, whether and how miR-27a participates in laryngeal cancer cell differentiation remains unknown. Therefore, we explored role and molecular mechanism of miR-27a in laryngeal cancer differentiation in the study. We found that miR-...
Autores principales: | Chen, Sheng, Sun, Yuan-Yuan, Zhang, Zhao-Xiong, Li, Yun-Hui, Xu, Zhen-Ming, Fu, Wei-Neng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362437/ https://www.ncbi.nlm.nih.gov/pubmed/28122350 http://dx.doi.org/10.18632/oncotarget.14769 |
Ejemplares similares
-
MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin
por: SU, JUAN, et al.
Publicado: (2011) -
MicroRNA-140-5p suppresses cell proliferation and invasion in gastric cancer by targeting WNT1 in the WNT/β-catenin signaling pathway
por: Cha, Yinlian, et al.
Publicado: (2018) -
MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma
por: Tian, Yuan, et al.
Publicado: (2014) -
MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway
por: Zhang, Xiaohui, et al.
Publicado: (2016) -
MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling
por: Shi, MingJun, et al.
Publicado: (2020)